Home
/
NowPatient Blog
/
Are upper respiratory tract infections contagious?

Are upper respiratory tract infections contagious?

Navin Khosla NowPatientGreen tick
Created on 16 Jul 2024
Updated on 16 Jul 2024

Upper respiratory tract infections (URIs), commonly known as the common cold, are some of the most widespread and frequently occurring illnesses worldwide. These infections involve the upper airways and include the sinuses, throat, airways, or lungs, are usually caused by viruses and can significantly impact your health health and well-being.

One of the main concerns surrounding URIs is their contagious nature. Their ability to spread from person to person is a critical factor in understanding their public health implications and the necessary preventive measures. Let’s delve into the contagious nature of upper respiratory infections, exploring how they are transmitted, factors that influence their spread, and ways to reduce the risk of infection.

Understanding upper respiratory tract infections

Upper respiratory tract infections (URIs) cover a range of conditions that affect the parts of the body involved in breathing. These include the sinuses, throat, airways, and lungs. The most common type of URI is the common cold, typically caused by viruses such as rhinoviruses, coronaviruses, and adenoviruses.

Common symptoms of upper respiratory tract infections

The symptoms of URIs often include:

  • Coughing
  • Sneezing
  • Stuffy or runny nose
  • Sore throats
  • Headaches
  • Body aches
  • Fever
  • Feeling generally unwell

While most URIs resolve within 1-2 weeks without the need for medical intervention, some cases may require more intensive treatment, especially in individuals with underlying health conditions or compromised immune systems.

Causes and types of upper respiratory tract infections

URIs are mainly caused by viruses that target the upper respiratory system. The most common types of URIs include:

  • Common cold
  • Sinusitis (sinus infection)
  • Tonsillitis (inflammation of the tonsils)
  • Pharyngitis (inflammation of the pharynx, uvula and tonsils)
  • Laryngitis ( inflammation of the larynx/voice box)
  • Influenza (flu)
  • Bronchitis
  • Pneumonia

These infections can be further categorised as either upper or lower respiratory tract infections, with lower RTIs (such as bronchitis and pneumonia) generally being more severe and long-lasting.

The contagious nature of upper respiratory tract infections

One of the characteristics of upper respiratory tract infections is their ability to spread from person to person. Understanding the transmission mechanisms is important in preventing the spread of infection.

Modes of transmission

URIs are typically transmitted through the following routes:

  • Respiratory droplets: When an infected person coughs, sneezes, or talks, they can release tiny droplets containing the virus into the air. These droplets can then be inhaled by other individuals nearby, leading to infection
  • Direct contact: The virus can also be transmitted through infected surfaces or objects, such as doorknobs, shared utensils, or contaminated hands. If a person touches these surfaces and then touches their eyes, nose, or mouth, the virus can enter the body
  • Airborne transmission: In some cases, the virus can become aerosolised and stay suspended in the air for an extended period, potentially infecting those not near the infected person

Factors influencing contagiousness

The contagiousness of upper respiratory tract infections can be influenced by various factors, including:

  • Viral strain: Different types of viruses can have varying levels of transmissibility and infectiousness
  • Environmental conditions: Temperature, humidity, and air circulation can affect the survival and spread of the virus
  • Host immune response: An individual’s immune system and overall health status can impact their chance of an infection and their ability to transmit the virus to others
  • Proximity and contact: The closer the contact between an infected individual and a susceptible person, the higher the risk of transmission
  • Seasonal patterns: Many URIs, such as influenza and respiratory syncytial virus (RSV), exhibit seasonal fluctuations

The incubation period and the contagious period

The incubation period for upper respiratory tract infections is the time between exposure to the virus and the onset of symptoms, and typically ranges from 1 to 5 days. During this time, individuals may be contagious and capable of transmitting the virus to others, even before they start experiencing symptoms.

The contagious period can vary depending on the specific pathogen and the individual’s immune response. For most viruses, the contagious period is usually around 7-10 days, but it can be longer for more severe infections like influenza.

Preventing the spread of upper respiratory tract infections

It is crucial to implement preventive measures to reduce the risk of transmission and protect both individual and public health.

Personal hygiene and sanitation

One of the most effective ways to prevent the spread of URIs is through good personal hygiene and sanitation practices:

  • Frequent handwashing with soap and water, or the use of alcohol-based hand sanitisers
  • Covering coughs and sneezes with a tissue or the inside of the elbow
  • Avoiding touching the face, especially the eyes, nose, and mouth
  • Regularly cleaning and disinfecting frequently touched surfaces and shared objects
  • Vaccination and immunisation

For certain upper respiratory tract infections, vaccination can provide a significant level of protection. Encouraging individuals, especially those at high risk (e.g., elderly, immunocompromised, or those with underlying medical conditions), to receive recommended vaccinations can help reduce the burden of these illnesses.

Social distancing and isolation

During periods of heightened URI transmission, implementing social distancing measures can be effective in limiting the spread of the infection. This may include:

  • Avoiding close contact with individuals who are sick
  • Staying home when experiencing URI symptoms
  • Limiting attendance at crowded events or gatherings

Healthy lifestyle habits

Maintaining a healthy lifestyle can also play a role in reducing the risk of contracting and spreading upper respiratory tract infections. This includes:

  • Getting enough sleep
  • Engaging in regular physical activity
  • Consuming a balanced, nutrient-rich diet and plenty of fluids
  • Managing stress levels
  • Avoiding smoking and excessive alcohol consumption

By adopting these preventive measures, individuals can contribute to the collective effort to limit the spread of upper respiratory tract infections and protect the health of their communities.

The role of healthcare providers

Healthcare professionals play a crucial role in managing and preventing upper respiratory tract infections. They can provide medical advice, education, and appropriate treatment to infected individuals and the general public.

Diagnosis and treatment

When individuals seek medical attention for URI symptoms, healthcare providers can perform diagnostic tests, such as physical examinations, and throat swabs to test for strep throat to determine the underlying cause of the infection. This allows for appropriate treatment, which may include:

  • Symptomatic relief through over-the-counter medications
  • Prescription of antibiotics for bacterial infections
  • Antiviral medicines for specific viral infections, such as influenza
  • Supportive care, including rest and hydration

Patient education and counselling

Healthcare providers can educate patients on the contagious nature of upper respiratory tract infections and guide preventive measures. This may include:

  • Explaining the modes of transmission and the importance of personal hygiene
  • Advising on the appropriate duration of isolation and when it is safe to return to work or school
  • Recommending vaccination for high-risk individuals
  • Promoting healthy lifestyle habits that can support the immune system

By working closely with patients and the broader community, healthcare professionals can play a pivotal role in slowing the spread of upper respiratory tract infections and promoting overall public health.

Pharmaceutical treatments

While many upper respiratory tract infections are self-limiting and can be managed with supportive care, conventional pharmaceutical treatments may be necessary in certain cases to alleviate symptoms or address underlying bacterial infections.

Analgesics and antipyretics

Pain relievers and fever-reducing medications, such as paracetamol and ibuprofen, can help manage the symptoms of URIs, as well as headaches, muscle aches, and fever. However, these medications do not address the underlying viral infection and may have potential risks, especially with prolonged or excessive use.

Antihistamines

Antihistamines, particularly first-generation, have been shown to have modest benefits in reducing nasal congestion and drainage associated with URIs. However, these medications may also cause sedation and other side effects.

Decongestants

Oral and topical decongestants can help reduce secretions from nasal passages by constricting blood vessels and decreasing fluid buildup. These medications should be used with caution, as they can have side effects such as increased heart rate, anxiety, and rebound congestion.

Cough suppressants

Cough suppressants, such as dextromethorphan and codeine, are commonly used to treat cough symptoms associated with upper respiratory tract infections. However, the evidence of their effectiveness is limited, and they may have potential side effects, particularly in children.

Combination formulas

Many over-the-counter cold and flu remedies contain a combination of various pharmaceutical ingredients, such as decongestants, antihistamines, and cough suppressants. While these combination products may provide some symptom relief, their effectiveness has not been extensively studied, and they may carry a higher risk of side effects.

It’s important to note that the use of antibiotics is generally not recommended for the treatment of upper respiratory tract infections, as they are primarily caused by viruses and are not effective against viral infections.

Conclusion

Upper respiratory tract infections, including the common cold, are highly contagious and can have significant impacts on individual and public health. Understanding the mechanisms of transmission, the factors that influence contagiousness, and the importance of preventive measures is crucial in reducing the spread of these illnesses.

Healthcare providers also have a vital part to play in the diagnosis, treatment, and education of patients, as well as in the overall management of these infections.

Sources

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Now Patient Data Security

Trusted and certified to keep your data safe.

Learn moreNow Patient Data Security
Now Patient Data Security

WHY WE BUILT NOWPATIENT

We are committed to helping everyone, everywhere live healthier lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

About NowPatient

Your Questions Answered

For your peace of mind, we can answer your questions quickly

What does NowPatient do?

NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.

Get started today and benefit from medication remindersGet Treated PrivatelyNHS online pharmacyGP appointment bookingRx savings cardDrug CouponsUS drug savings programshealth conditions informationgenetic testinghome test kitsBMI RisksType 2 Diabetes Riskspollen meterair quality monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.

UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.

US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

We do not provide any prescribing services or dispensing services in the United States.

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111

Find more answers